We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+11.96%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$445M
AUM Growth
+$51.4M
Cap. Flow
+$26.8M
Cap. Flow %
6.02%
Top 10 Hldgs %
13.28%
Holding
846
New
291
Increased
146
Reduced
137
Closed
271

Top Buys

Rank Stock Value
1
KR icon
Kroger
KR
+$8.18M
2
ACN icon
Accenture
ACN
+$8.18M
3
GIS icon
General Mills
GIS
+$7.58M
4
LULU icon
lululemon athletica
LULU
+$5.81M
5
BBBY
Bed Bath & Beyond Inc
BBBY
+$4.82M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.7%
2 Technology 21.58%
3 Industrials 13.12%
4 Healthcare 11.03%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
201
People Inc
PPLI
$3.15B
$650K 0.15%
+23,859
New +$653K
TREX icon
202
Trex
TREX
$4.57B
$649K 0.15%
+20,736
New +$601K
BILI icon
203
Bilibili
BILI
$7.47B
$648K 0.15%
+46,300
New +$631K
PEN icon
204
Penumbra
PEN
$12.6B
$647K 0.15%
4,686
+784
+20% +$112K
LAMR icon
205
Lamar Advertising Co
LAMR
$16.3B
$642K 0.14%
+9,400
New +$630K
ZWS icon
206
Zurn Elkay Water Solutions
ZWS
$8.14B
$642K 0.14%
45,880
+2,699
+6% +$38.2K
MSI icon
207
Motorola Solutions
MSI
$70.3B
$640K 0.14%
5,500
-8,775
-61% -$967K
GDOT icon
208
Green Dot
GDOT
$746M
$637K 0.14%
8,674
+100
+1% +$6.89K
CNDT icon
209
Conduent
CNDT
$234M
$636K 0.14%
35,000
-16,100
-32% -$311K
NKTR icon
210
Nektar Therapeutics
NKTR
$2.41B
$635K 0.14%
867
+369
+74% +$425K
SHAK icon
211
Shake Shack
SHAK
$2.48B
$635K 0.14%
+9,590
New +$532K
WU icon
212
Western Union
WU
$2.55B
$628K 0.14%
30,900
+15,500
+101% +$309K
GLOB icon
213
Globant
GLOB
$1.41B
$627K 0.14%
+11,041
New +$552K
USNA icon
214
Usana Health Sciences
USNA
$412M
$623K 0.14%
+5,404
New +$591K
CC icon
215
Chemours
CC
$2.55B
$622K 0.14%
14,024
-5,076
-27% -$253K
WMT icon
216
Walmart Inc
WMT
$889B
$617K 0.14%
+21,600
New +$614K
ELLI
217
DELISTED
Ellie Mae Inc
ELLI
$617K 0.14%
5,939
+400
+7% +$40.6K
WEX icon
218
WEX
WEX
$6.17B
$612K 0.14%
3,214
-260
-7% -$45.3K
MOV icon
219
Movado Group
MOV
$835M
$611K 0.14%
+12,652
New +$546K
THC icon
220
Tenet Healthcare
THC
$21B
$611K 0.14%
18,200
-23,600
-56% -$734K
BHC icon
221
Bausch Health
BHC
$1.67B
$604K 0.14%
+26,000
New +$538K
ARRS
222
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$601K 0.14%
+24,600
New +$647K
RNG icon
223
RingCentral
RNG
$4.5B
$598K 0.13%
8,500
+2,800
+49% +$200K
SMTC icon
224
Semtech
SMTC
$11.3B
$598K 0.13%
12,700
-4,300
-25% -$193K
EXPR
225
DELISTED
Express, Inc.
EXPR
$596K 0.13%
+3,256
New +$565K

Similar funds

Bayesian Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bayesian Capital Management held 846 positions worth $445M, up 13% from $393M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bayesian Capital Management deployed $26.8M of net new capital in Q2 2018, opening 291 new positions and adding to 146 existing holdings. Its largest new stake was Kroger: 325,365 shares worth $9.26M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $14.8M trimmed.

  • Bayesian Capital Management's largest Q2 2018 buy was Kroger: 325,365 shares worth $9.26M.
  • Bayesian Capital Management added most to Burlington in Q2 2018, an estimated $3.26M increase.
  • Bayesian Capital Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.8M.
  • Bayesian Capital Management fully exited Nike in Q2 2018, selling an estimated $3.43M.
  • Bayesian Capital Management's ten largest holdings make up 13% of its $445M portfolio in Q2 2018.
  • Bayesian Capital Management opened 291 new positions and closed 271 in Q2 2018.
  • Bayesian Capital Management's portfolio value rose 13% quarter-over-quarter to $445M.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.